Coley, W. B. (1893). The treatment of malignant tumors by repeated inoculations of erysipelas: With a report of ten original cases. American Journal of the Medical Sciences, 10, 487–511.
Saxena, M., van der Burg, S. H., Melief, C. J. M., & Bhardwaj, N. (2021). Therapeutic cancer vaccines. Nature Reviews Cancer, 21(6), 360–378. https://doi.org/10.1038/s41568-021-00346-0
Article CAS PubMed Google Scholar
Prehn, R. T., & Main, J. M. (1957). Immunity to methylcholanthrene-induced sarcomas. Journal of the National Cancer Institute, 18(6), 769–778.
Kaczmarek, M., Poznańska, J., Fechner, F., Michalska, N., Paszkowska, S., Napierała, A., & Mackiewicz, A. (2023). Cancer vaccine therapeutics: Limitations and effectiveness—A literature review. Cells, 12(17), 2159. https://doi.org/10.3390/cells12172159
Article CAS PubMed PubMed Central Google Scholar
Mole, R. H. (1953). Whole body irradiation; radiobiology or medicine? British Journal of Radiology, 26(305), 234–241. https://doi.org/10.1259/0007-1285-26-305-234
Article CAS PubMed Google Scholar
Nobler, M. P. (1969). The abscopal effect in malignant lymphoma and its relationship to lymphocyte circulation. Radiology, 93, 410–412.
Article CAS PubMed Google Scholar
Deneufbourg, J. M. (1975). Radiocurability of a transplantable murine sarcoma as influenced by immune competence of the host and adjuvant active specific immunotherapy. Strahlentherapie, 149(4), 457–462.
Tsuchiya, T. (1976). The role of immune response following local irradiation. I. Anti-tumor cell-mediated immunity (author’s transl). Nihon Igaku Hoshasen Gakkai Zasshi, 36(10), 922–9. Japanese.
Keisari, Y., Popovtzer, A., & Kelson, I. (2020). Effective treatment of metastatic cancer by an innovative intratumoral alpha particle-mediated radiotherapy in combination with immunotherapy: A short review. Journal of Physics: Conference Series, 1662, 012016. https://doi.org/10.1088/1742-6596/1662/1/012016
Vroomen, L. G. P. H., Petre, E. N., Cornelis, F. H., Solomon, S. B., & Srimathveeravalli, G. (2017). Irreversible electroporation and thermal ablation of tumors in the liver, lung, kidney and bone: What are the differences? Diagnostic and Interventional Imaging, 98(9), 609–617. https://doi.org/10.1016/j.diii.2017.07.007
Article CAS PubMed Google Scholar
Keisari, Y. (2017). Tumor abolition and antitumor immunostimulation by physico-chemical tumor ablation. Frontiers Biosc (Landmark Edition), 22, 310–347.
Keisari, Y. (2013). Tumor ablation: Effects on systemic and local anti-tumor immunity and on other tumor-microenvironment interactions. Springer. https://www.springer.com/gp/book/9789400746930.
Demaria, S., Guha, C., Schoenfeld, J., Morris, Z., Monjazeb, A., Sikora, A., Crittenden, M., Shiao, S., Khleif, S., Gupta, S., Formenti, S. C., Vikram, B., Coleman, C. N., & Ahmed, M. M. (2021). Radiation dose and fraction in immunotherapy: One-size regimen does not fit all settings, so how does one choose? Journal for Immunotherapy of Cancer, 9(4), e002038. https://doi.org/10.1136/jitc-2020-002038
Article PubMed PubMed Central Google Scholar
Keisari, Y., & Kelson, I. (2021). The potentiation of anti-tumor immunity by tumor abolition with alpha particles, protons or carbon ion radiation and its enforcement by combination with immunoadjuvants or inhibitors of immune suppressor cells and check point molecules. Cells, 10, 228. https://doi.org/10.3390/cells10020228
Article CAS PubMed PubMed Central Google Scholar
Galluzzi, L., Humeau, J., Buqué, A., Zitvogel, L., & Kroemer, G. (2020). Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nature Reviews. Clinical Oncology, 17(12), 725–741. https://doi.org/10.1038/s41571-020-0413-z
Erinjeri, J. P., Fine, G. C., Adema, G. J., Ahmed, M., Chapiro, J., den Brok, M., Duran, R., Hunt, S. J., Johnson, D. T., Ricke, J., Sze, D. Y., Toskich, B. B., Wood, B. J., Woodrum, D., & Goldberg, S. N. (2019). Immunotherapy and the interventional oncologist: Challenges and opportunities-A society of interventional oncology white paper. Radiology, 292(1), 25–34. https://doi.org/10.1148/radiol.2019182326
Kornepati, A. V. R., Rogers, C. M., Sung, P., & Curiel, T. J. (2023). The complementarity of DDR, nucleic acids and anti-tumour immunity. Nature, 619(7970), 475–486. https://doi.org/10.1038/s41586-023-06069-6
Article CAS PubMed Google Scholar
Ye, Z., Shi, Y., Lees-Miller, S. P., & Tainer, J. A. (2021). Function and molecular mechanism of the DNA damage response in immunity and cancer immunotherapy. Frontiers in Immunology, 12, 797880. https://doi.org/10.3389/fimmu.2021.797880
Article CAS PubMed PubMed Central Google Scholar
van den Bijgaart, R. J. E., Schuurmans, F., Fütterer, J. J., Verheij, M., Cornelissen, L. A. M., & Adema, G. J. (2021). Immune modulation plus tumor ablation: Adjuvants and antibodies to prime and boost anti-tumor immunity in situ. Frontiers in Immunology, 12, 617365. https://doi.org/10.3389/fimmu.2021.617365
Article CAS PubMed PubMed Central Google Scholar
Baude, J., Limagne, E., Ladjohounlou, R., & Mirjolet, C. (2023). Combining radiotherapy and NK cell-based therapies: The time has come. International Review of Cell and Molecular Biology, 378, 31–60. https://doi.org/10.1016/bs.ircmb.2023.02.003
Lamichhane, P., Amin, N. P., Agarwal, M., & Lamichhane, N. (2018). Checkpoint inhibition: Will combination with radiotherapy and nanoparticle-mediated delivery improve efficacy? Medicines (Basel), 5(4), 114. https://doi.org/10.3390/medicines5040114
Article CAS PubMed Google Scholar
Shannon, A. H., Manne, A., Diaz Pardo, D. A., & Pawlik, T. M. (2023). Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma. Frontiers in Oncology, 13, 1193762. https://doi.org/10.3389/fonc.2023.1193762
Article CAS PubMed PubMed Central Google Scholar
Yang, X., Gao, M., Xu, R., Tao, Y., Luo, W., Wang, B., Zhong, W., He, L., & He, Y. (2022). Hyperthermia combined with immune checkpoint inhibitor therapy in the treatment of primary and metastatic tumors. Frontiers in Immunology, 13, 969447. https://doi.org/10.3389/fimmu.2022.969447
Article CAS PubMed PubMed Central Google Scholar
Eresen, A., Yang, J., Scotti, A., Cai, K., Yaghmai, V., & Zhang, Z. (2021). Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma. Ann Transl Med, 9(13), 1089. https://doi.org/10.21037/atm-21-539
Article CAS PubMed PubMed Central Google Scholar
Persa, E., Balogh, A., Sáfrány, G., & Lumniczky, K. (2015). The effect of ionizing radiation on regulatory T cells in health and disease. Cancer Letters, 368(2), 252–261. https://doi.org/10.1016/j.canlet.2015.03.003
Article CAS PubMed Google Scholar
Markezana, A., Goldberg, S. N., Kumar, G., Zorde-Khvalevsky, E., Gourevtich, S., Rozenblum, N., Galun, E., & Ahmed, M. (2021). Incomplete thermal ablation of tumors promotes increased tumorigenesis. International Journal of Hyperthermia, 38(1), 263–272. https://doi.org/10.1080/02656736.2021.1887942
Comments (0)